PRINCETON, N.J., March 16 /PRNewswire/ -- Tickerspy (http://www.tickerspy.com), an investing website featuring over 250 unique, proprietary Indexes, announced the creation of the Chinese Healthcare Stocks Index, which includes among its components American Oriental Bioengineering (NYSE: AOB), Sinovac Biotech (Nasdaq: SVA), Mindray Medical International (NYSE: MR), China Medical Technologies (Nasdaq: CMED), WuXi PharmaTech (NYSE: WX), China Sky One Medical (Nasdaq: CSKI), Tianyin Pharmaceutical (AMEX: TPI), China-Biotics (Nasdaq: CHBT), and several others.
The Chinese Healthcare Stocks Index is up more than 5% over the last month as earnings throughout the segment have moved the component stocks. The Index is up by nearly 30% versus the S&P 500 since the start of 2008. To gain immediate access the Chinese Healthcare Stocks Index, a complete list of its components, and various charts and related metrics, visit the following link:
Tickerspy Indexes use a "net asset value" calculation and cover a wide range of market sectors and segments, including dry bulk shipping stocks, Canadian energy trusts, gold and silver stocks, uranium stocks, money center banks, and many more. Tickerspy also offers ten different Chinese Indexes, including for Chinese Solar stocks, Chinese IT stocks, and Chinese agriculture stocks.
Tickerspy is a free, stock market-focused website that lets users track proprietary Indexes and institutional holdings. Tickerspy members can also track each other's portfolios and share investment ideas and news. In addition, tickerspy members receive a free, customized daily email that includes portfolio performance, alerts, and news on the stocks they are tracking.
NOTE: This release was published by Indie Research Advisors, LLC, a registered investment advisor with CRD #131926. Interested parties may visit adviserinfo.sec.gov for additional information. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
CONTACT: Marcia Martin, tickerspy, +1-888-278-5515
SOURCE Indie Research Advisors, LLCBack to top
|SOURCE Indie Research Advisors, LLC|
Copyright©2010 PR Newswire.
All rights reserved